These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
365 related articles for article (PubMed ID: 19119630)
1. [The expression of fibrillin 1 in pathologic scars and its significance]. Nie FF; Wang Q; Qin ZL Zhonghua Zheng Xing Wai Ke Za Zhi; 2008 Sep; 24(5):339-42. PubMed ID: 19119630 [TBL] [Abstract][Full Text] [Related]
2. Co-localization of LTBP-2 with FGF-2 in fibrotic human keloid and hypertrophic scar. Sideek MA; Teia A; Kopecki Z; Cowin AJ; Gibson MA J Mol Histol; 2016 Feb; 47(1):35-45. PubMed ID: 26644005 [TBL] [Abstract][Full Text] [Related]
3. Fibrillin-1 and elastin are differentially expressed in hypertrophic scars and keloids. Amadeu TP; Braune AS; Porto LC; Desmoulière A; Costa AM Wound Repair Regen; 2004; 12(2):169-74. PubMed ID: 15086768 [TBL] [Abstract][Full Text] [Related]
4. [The expression of periostin in hyperplasic scars and the relations to TGF-beta1 and its receptors]. Wang Q; Nie FF; Zhao X; Qin ZL Zhonghua Zheng Xing Wai Ke Za Zhi; 2007 May; 23(3):229-32. PubMed ID: 17649947 [TBL] [Abstract][Full Text] [Related]
5. [Expression of thymosin beta 4 mRNA expression in keloid tissues and fibroblasts cultured from keloid and its significance]. Nie FF; Wu JQ; Qin ZL Zhongguo Wei Zhong Bing Ji Jiu Yi Xue; 2005 Feb; 17(2):80-3. PubMed ID: 15698487 [TBL] [Abstract][Full Text] [Related]
6. [Changes in TGF-beta 1 and type I, III procollagen gene expression in keloid and hypertrophic scar]. Tang S; Pang S; Cao Y Zhonghua Zheng Xing Shao Shang Wai Ke Za Zhi; 1999 Jul; 15(4):283-5. PubMed ID: 11593607 [TBL] [Abstract][Full Text] [Related]
7. [Expression of mast cell tryptase in scar]. Gao F; Zhao Y; Feng YQ; Huo R; Xue WJ; Wang FG; Lv RR; Xue F; Li Q; Zhang J Zhonghua Zheng Xing Wai Ke Za Zhi; 2010 Mar; 26(2):132-5. PubMed ID: 20540319 [TBL] [Abstract][Full Text] [Related]
9. Bone marrow derived mesenchymal stem cells inhibit the proliferative and profibrotic phenotype of hypertrophic scar fibroblasts and keloid fibroblasts through paracrine signaling. Fang F; Huang RL; Zheng Y; Liu M; Huo R J Dermatol Sci; 2016 Aug; 83(2):95-105. PubMed ID: 27211019 [TBL] [Abstract][Full Text] [Related]
10. Cross-talk between TGF-β/Smad pathway and Wnt/β-catenin pathway in pathological scar formation. Sun Q; Guo S; Wang CC; Sun X; Wang D; Xu N; Jin SF; Li KZ Int J Clin Exp Pathol; 2015; 8(6):7631-9. PubMed ID: 26261683 [TBL] [Abstract][Full Text] [Related]
11. Effect of heparin on production of transforming growth factor (TGF)-beta1 and TGF-beta1 mRNA expression by human normal skin and hyperplastic scar fibroblasts. Fan SQ; Cai JL; Qin LY; Wang ZH; Liu ZZ; Sun ML Ann Plast Surg; 2008 Mar; 60(3):299-305. PubMed ID: 18443513 [TBL] [Abstract][Full Text] [Related]
12. [The expression of SnoN in human hypertrophic scar fibroblasts and the mechanism of its participation in hypertrophic scar formation]. Kuang F; Zhang Z; Chen B; Liu CL; Zhao YY; Xu ZR; Li XJ Zhonghua Shao Shang Za Zhi; 2017 Oct; 33(10):634-638. PubMed ID: 29056026 [No Abstract] [Full Text] [Related]
13. Studies of transforming growth factors beta 1-3 and their receptors I and II in fibroblast of keloids and hypertrophic scars. Bock O; Yu H; Zitron S; Bayat A; Ferguson MW; Mrowietz U Acta Derm Venereol; 2005; 85(3):216-20. PubMed ID: 16040405 [TBL] [Abstract][Full Text] [Related]
14. [Relationship between angiogenesis and expression of HO-1 of scar]. Zhu J; Luo CQ; He QY; Peng H; Zhou JD; Li P Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2005 Jun; 30(3):335-9. PubMed ID: 16045028 [TBL] [Abstract][Full Text] [Related]
15. Immunohistochemical expression of TGF-β1 in keloids and hypertrophic scars. Abdou AG; Maraee AH; Al-Bara AM; Diab WM Am J Dermatopathol; 2011 Feb; 33(1):84-91. PubMed ID: 20559120 [TBL] [Abstract][Full Text] [Related]
16. Smad interacting protein 1 as a regulator of skin fibrosis in pathological scars. Zhang ZF; Zhang YG; Hu DH; Shi JH; Liu JQ; Zhao ZT; Wang HT; Bai XZ; Cai WX; Zhu HY; Tang CW Burns; 2011 Jun; 37(4):665-72. PubMed ID: 21236582 [TBL] [Abstract][Full Text] [Related]
17. Characterization of In Vitro Reconstructed Human Normotrophic, Hypertrophic, and Keloid Scar Models. Limandjaja GC; van den Broek LJ; Breetveld M; Waaijman T; Monstrey S; de Boer EM; Scheper RJ; Niessen FB; Gibbs S Tissue Eng Part C Methods; 2018 Apr; 24(4):242-253. PubMed ID: 29490604 [TBL] [Abstract][Full Text] [Related]
18. Analysis of protease-activated receptor-1 and -2 in human scar formation. Materazzi S; Pellerito S; Di Serio C; Paglierani M; Naldini A; Ardinghi C; Carraro F; Geppetti P; Cirino G; Santucci M; Tarantini F; Massi D J Pathol; 2007 Aug; 212(4):440-9. PubMed ID: 17597495 [TBL] [Abstract][Full Text] [Related]
19. Regulatory mechanism of miR-29 over TGF-β1 and COL1 in scar cells. Bi S; Cao C; Chai LL; Li SR; Yang DY Eur Rev Med Pharmacol Sci; 2017 May; 21(10):2512-2517. PubMed ID: 28617563 [TBL] [Abstract][Full Text] [Related]
20. The Effects of the Transforming Growth Factor-β1 (TGF-β1) Signaling Pathway on Cell Proliferation and Cell Migration are Mediated by Ubiquitin Specific Protease 4 (USP4) in Hypertrophic Scar Tissue and Primary Fibroblast Cultures. Huang Y; Wang Y; Wang X; Lin L; Wang P; Sun J; Jiang L Med Sci Monit; 2020 Apr; 26():e920736. PubMed ID: 32308208 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]